Thyroid Tablets recall (VITRUVIAS THERAPEUTICS INC)
DrugClass IOngoing
Summary: VITRUVIAS THERAPEUTICS INC is recalling Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.. Reason: Superpotent Drug.
What is being recalled
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Why
Superpotent Drug
How serious is it
Class I is the most serious level: FDA considers there is a reasonable probability that using or being exposed to this product will cause serious health problems or death.
Where it was sold
US Nationwide.
How to tell if yours is affected
Lot # 504950, Exp Date: 09/30/2026.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0866-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class I |
| Status | Ongoing |
| Recall started | August 21, 2026 |
| Reported | September 23, 2026 |
| Company | VITRUVIAS THERAPEUTICS INC |
| Company location | Auburn, AL, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 1955 bottles |
More recalls from VITRUVIAS THERAPEUTICS INC · all drug recalls · recalls from August 2026